Sales of vitamins, totaling almost $3.6 billion, were up 2.7% for the 52 weeks ended May 13, according to SymphonyIRI Group data across food drug and mass (excluding Walmart).
And according to a recent TABS Group analysis, that growth came despite the percentage of U.S. vitamin users in 2012 decreasing from 71% to 66% — trade-ups, price inflation and the increased use emanating from current buyers purchasing more vitamins were the drivers behind today’s growth, said Kurt Jetta, TABS Group CEO.